Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Can CAR-T Therapy Drive HEMO's Future Growth?

HemoGenyx Pharmaceuticals PLC (LSE:HEMO) is a clinical-stage biotechnology company focused on developing innovative cell therapies and immunotherapies for the treatment of blood cancers and autoimmune diseases.

Divya Sood | 21 July 2026

Can Commercial Partnerships Accelerate 4basebio's Growth?

4basebio PLC shares declined4.76%, making the biotechnology company one of the weaker performers among London-listed life sciences stocks during the trading session. The decline inLSE:4BBcomes as investors continue to evaluate commercial progress, research partnerships and funding expectations across the biotechnology sector.

Divya Sood | 21 July 2026

Oxford BioMedica (LSE:OXB) Stock Slides 5.88%: What's Driving Investor Caution Despite Strong Long-Term Growth Potential?

Oxford BioMedica plc (LSE:OXB) attracted significant investor attention after its shares fell5.88%during trading on20 July 2026. Although no single major corporate event fully explained the decline, the movement reflected a combination of company-specific sentiment and broader market dynamics affecting biotechnology and healthcare stocks.

Ankur Sharma | 21 July 2026

MedPal AI (LSE:MPAL): Can Its Expanding AI-Healthcare Platform Live Up to the Growing Investor Attention?

Key takeawaysMedPal AI plc joined AIM in August 2025 and runs a vertically integrated model spanning an AI health app, clinician-validated prescribing and automated pharmacy dispensing, led by CEO Jason Drummond.Half-year revenue to 28 February 2026 was about £1.6 million from a standing start, …

Ankur Sharma | 20 July 2026

Imaging Biometrics (LSE:IBAI): The Brain-Cancer Software Micro-Cap With Real ASCO-Validated Data

Key takeawaysThe company trading as LSE:IBAI is Imaging Biometrics Limited, a Jersey-incorporated business on the London Stock Exchange's Main Market; it was renamed from IQ-AI Limited (LSE:IQAI) in 2025 and traces back to the former Flying Brands shell.Its core commercial product is IB Neuro, …

Ankur Sharma | 20 July 2026

Can Ondine Biomedical, Inc. Sustain Its Position in Biotechnology & Medical Devices?

Ondine Biomedical, Inc. (OBI)Ondine Biomedical, Inc. is a biotechnology company involved in the research and development of therapeutic or diagnostic products.

Ishan Mudgal | 20 July 2026

MedPal AI Shares Climb: Why Is MPAL Stock Catching Investors' Attention?

• MPAL shares gained 2.94% on 20 July 2026, closing at 3.50 GBX.• MedPal AI PLC has a market capitalization of approximately 26.17 million GBP, placing it in the micro-cap segment.• The company focuses on artificial intelligence-driven healthcare and digital health technology solutions.• Product …

Ankur Sharma | 20 July 2026

Can HemoGenyx Pharmaceuticals Plc Sustain Its Position in Biotechnology & Pharmaceuticals?

HemoGenyx Pharmaceuticals Plc (HEMO)HemoGenyx Pharmaceuticals Plc is a biotechnology company involved in the research and development of therapeutic or diagnostic products.

Ishan Mudgal | 20 July 2026

Can Faron Pharmaceuticals Oy Sustain Its Position in Biotechnology & Pharmaceuticals?

Faron Pharmaceuticals Oy (FARN)Faron Pharmaceuticals Oy is a biotechnology company involved in the research and development of therapeutic or diagnostic products.

Ishan Mudgal | 20 July 2026

Can Craneware plc Sustain Its Position in Healthcare Technology & Software?

Craneware plc (CRW)Craneware plc is a technology company providing software, data, or digital solutions.

Ishan Mudgal | 20 July 2026
Support

Hi! How can we help you today?

Loading…